Partnerships

ERA for Health

ERA for Health

Partnership website: https://era4health.eu/

The partnership aims at establishing a flexible and effective coordination between funding organisations in the European Research Area (ERA) for Health and Well-being. The Partnership started its activities in November 2022. Flanders is actively involved.

The Partnership 'Fostering a European Research Area for Health' (ERA4Health) brings the opportunity to increase European transnational collaborative research funding by creating a funding body for joint programming in priority areas addressing European public health needs. 

Participation Flanders

The Partnership brings together 33 partners and 27 funding organisations from 22 countries. Among the consortium partners are Research Foundation Flanders (FWO) and Flanders Research Institute for Agriculture, Fisheries and Food (ILVO). 

Located in Flanders & interested in the Partnership? Consult the dedicated FWO webpage. 

Past calls for proposals

  • CARDINNOV - Reserach targeting development of innovative therapeutic strategies in cardiovascular disease. 
  • HealthEquity - Increasing health equity through promoting healthy diets and physical activity. 
  • NutriBrain - Modulation of brain ageing through nutrition and healthy lifestyle
  • NANOTECMEC - Nano and advanced technologies for disease prevention, diagnostic and therapy
  • INTERHEART - Understanding the interactions between cardiovascular diseases and comorbidities and/or their therapeutic treatments

You can register to the ERA4Health newsletter to stay informed about upcoming calls for proposals here: Newsletter - ERA4HEALTH

Key documents

Contact

Commission services: RTD-SANTE-HE-HEALTH-CLUSTER@ec.europa.eu

Partnership: Contact - ERA4HEALTH

What are partnerships?

Partnerships group the EC and private and/or public partners, to coordinate and streamline the research & innovation initiatives and funding in some selected key domains.

More detailed info Overview of partnerships

How to use partnerships?

  • orientation
    Partnerships publish strategic documents, e.g. outlining the main research and innovation challenges or key focus points.
  • networking
    Partnerships often organise events, such as info days, brokerage events, etc. Meet potential partners and learn about the nuances that are not visible in the official documents.
  • ecosystem analysis
    Partnerships typically have an advisory board, and publish impact studies of previous actions. These are good sources of information to uncover the main R&D&I players in the domain.
  • steering the agenda
    Partnerships collaborate with the EC on outlining the strategy and the future funding opportunities in their domain, based on input from industry, academia, and other stakeholders.

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.

Read the full article Check out the other testimonials 
Logo of FWO
Logo of VLAIO

NCP Flanders

Updates

Our Services

Legal mentions

Privacy Policy
Cookies

LinkedIn